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Supplemental Table I. Summary of clinical details for each patient cohort 
Patient cohort Training (n = 49) Validation (n = 11) 
Age (mean ± SD) 72 ± 15 75 ± 16 
Sex, female 20 (41%) 4 (36%) 
Etiology 
   Large artery atherosclerosis 
   Cardioembolism 
      Atrial fibrillation 
      Infective endocarditis 
      Cardiomyopathy 
      Left ventricular thrombus 
      Mechanical prosthetic valve 
Number of thrombi 
   Large artery atherosclerosis 



























   ICA 
   ICA + MCA M1 
   MCA M1 
   MCA M1 + M2 
   MCA M2 
   Vertebrobasilar 
EVT technique 
   Stent 





















Prior stroke 10 (20%) 2 (18%) 
Hypertension 34 (69%) 8 (73%) 
Diabetes 6 (12%) 3 (27%) 
Obesity 





Hyperlipidemia 23 (47%) 7 (64%) 
Coronary artery disease 10 (20%) 5 (45%) 
Cardiac valve disease 4 (8%) 1 (9%) 
Chronic kidney disease 0 (0%) 2 (18%) 
EVT indicates endovascular therapy; ICA, internal carotid artery; IV tPA, intravenous 




Supplemental Table II. Texture features examined for model inclusion in this study 
















Gray-level run-length matrix 
(GLRLM) 
Short Run Emphasis (SRE) 
Long Run Emphasis (LRE) 
Gray-Level Non-uniformity (GLN) 
Run-Length Non-uniformity (RLN) 
Run Percentage (RP) 
Low Gray-Level Run Emphasis (LGRE) 
High Gray-Level Run Emphasis (HGRE) 
Short Run Low Gray-Level Emphasis (SRLGE) 
Short Run High Gray-Level Emphasis (SRHGE) 
Long Run Low Gray-Level Emphasis (LRLGE) 
Long Run High Gray-Level Emphasis (LRHGE) 
Gray-Level Variance (GLV) 
Run-Length Variance (RLV) 
Gray-level size zone matrix 
(GLSZM) 
Small Zone Emphasis (SZE) 
Large Zone Emphasis (LZE) 
Gray-Level Non-uniformity (GLN) 
Zone-Size Non-uniformity (ZSN) 
Zone Percentage (ZP) 
Low Gray-Level Zone Emphasis (LGZE) 
High Gray-Level Zone Emphasis (HGZE) 
Small Zone Low Gray-Level Emphasis (SZLGE) 
Small Zone High Gray-Level Emphasis 
(SZHGE) 
Large Zone Low Gray-Level Emphasis (LZLGE) 
Large Zone High Gray-Level Emphasis 
(LZHGE) 
Gray-Level Variance (GLV) 
Zone-Size Variance (ZSV) 
Neighbourhood gray-tone 










Supplemental Table III. Clinical details of CE and LAA stroke patients within the training 
cohort 
Characteristic CE (n = 41) LAA (n = 8) P value 
Age (years) 74 ± 15 61 ± 10 0.028 


































1 (1 - 2) 
46 (29 - 66) 
1.2 (0.9 - 1.6) 
3.5 (3.0 - 4.2) 
1.0 (0.8 - 1.2) 
1.9 ± 0.7 
5.6 (5.3 - 5.9) 
8.3 (7.0 - 10.4) 
23 (8 - 49) 
38 (32 - 48) 
30 (73%) 
4.6 ± 0.8 
13 (32%) 





































1 (1 - 1) 
86 (67 – 131) 
1.9 (1.5 - 5.8) 
4.4 (4.4 - 5.9) 
0.9 (0.7 - 1.2) 
2.8 ± 1.0 
6.6 (6.2 - 7.6) 
9.2 (7.6 - 10.8) 
9 (5 - 25) 
25 (19 - 30) 
1 (13%) 
4.5 ± 0.7 
1 (13%) 




Prior stroke 0.73 




Coronary artery disease 0.12 
Cardiac valve disease 0.36 
Peripheral artery disease 0.43 
Smoking, past 5 years 
Obesity 






   0 
   1 
   2A 
   2B 
   3 
Arrival NIHSS 
Occlusion side: 
   Right 
   Left 
   Unknown 
Occlusion site: 
   ICA 
   ICA + MCA M1 
   MCA M1 
   MCA M1 + M2 
   MCA M2 
   Vertebrobasilar 
EVT passes 





Glucose (hemoglobin A1c; %) 
Leukocytes (109/L) 
Troponin (ng/L) 
Left atrial volume index (mL/m2) 
Left atrial enlargement 
Left ventricular diameter (cm) 
Left ventricular hypertrophy 
Left ventricular ejection fraction 











































EVT indicates endovascular therapy; HDL, high-density lipoprotein; ICA, internal carotid 
artery; IV tPA, intravenous recombinant tissue plasminogen activator; LDL, low-density 
lipoprotein; MCA, middle cerebral artery; NIHSS, National Institutes of Health stroke scale;  
TIA, transient ischemic attack; and TICI, thrombolysis in cerebral infarction. 
